-
Sanofi: Expected to contribute over 10 billion euros in newly launched innovative drugs by 2030
On December 8th, Shanghai, Xinhua Finance and Economics reported that Sanofi's investor research and development day was recently held. Sanofi announced 12 new molecular entities with the potential f ... -
Novo Nordisk plans to introduce weight loss oral small molecule drugs for 235 million euros
On January 23rd, Novo Nordisk announced a cooperation and licensing agreement with EraCal Therapeutics to develop and commercialize EraCal as a weight loss oral small molecule drug. It is reported th ...